MAB Discovery
Pre-clinicalMAB Discovery GmbH was founded in 2010 by Dr. Stephan Fischer and started operations in 2011 with experienced pharma scientists utilizing a unique discovery process to develop high quality, functional monoclonal antibodies for therapies in the area of oncology, immunology and inflammatory diseases. MAB Discovery successfully generated various mAbs for pharma partners – in 2023 eight projects have reached the clinic.
About
MAB Discovery GmbH was founded in 2010 by Dr. Stephan Fischer and started operations in 2011 with experienced pharma scientists utilizing a unique discovery process to develop high quality, functional monoclonal antibodies for therapies in the area of oncology, immunology and inflammatory diseases. MAB Discovery successfully generated various mAbs for pharma partners – in 2023 eight projects have reached the clinic.
Funding History
2Total raised: $19M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile